The Vascular medicine deparment has a strong focus on optimisation of diagnosis and treatment of athero-thrombotic diseases. The deparment has a longlasting reputation on early translational research of innovative therapies in humans (gene therapy, antisense, small molecules), surrogate marker studies for cardiovascular disease (ultrasound, MRI), diagnostic studies (thrombosis/pulmonary embolism) and RCTs in atherothrombosis.

In addition, a dedicated clinical/research program for patients with cardiovascular genetic diseases (lipids, thrombosis, premature atherosclerosis) has been implemented. The ambition of the department is to unravel novel mechanisms contributing to atherothrombotic disease, as well as to evaluate novel diagnostic and therapeutic strategies for atherothrombotic diseases. The research is conducted in close collaboration with the department of Experimental Vascular Medicine.